User talk:Danieldis47: Difference between revisions
Danieldis47 (talk | contribs) mNo edit summary |
Danieldis47 (talk | contribs) |
||
Line 74: | Line 74: | ||
Archimedes, Inc. was founded by David Eddy, MD PhD, and Leonard Schlessinger, PhD, when they moved on from not-for-profit managed-care organization [[Kaiser Permanente]] in January 2006 to form their own company.<ref name=businessweek29May2006>Carey, John. (May 29, 2006) [http://www.businessweek.com/magazine/content/06_22/b3986001.htm “Medical Guesswork”] ''Businessweek.''</ref> Archimedes helps healthcare organizations improve the quality and efficiency of their programs and services.<ref name=businessweek29May2006 /> Its proprietary software, the Archimedes Model, allows for a better understanding of the implications of medical decisions. It can be applied to a range of real world scenarios, including physiological changes, physician behavior, cost and patient decision implications.<ref name=wired15Nov2009>Kahn, Jennifer. (December, 2009) [http://www.wired.com/magazine/2009/11/ff_archimedes/all/1 “Modeling Human Drug Trials — Without the Human”] ''Wired.''</ref> The company's staff includes scientists, physicians and software engineers.<ref>{{Cite web|work=[[Archimedes, Inc]]|url= http://archimedesmodel.com/about-archimedes-incorporated.html|title=About Archimedes|date=January 1, 2010|accessdate=September 1, 2010}}</ref> |
Archimedes, Inc. was founded by David Eddy, MD PhD, and Leonard Schlessinger, PhD, when they moved on from not-for-profit managed-care organization [[Kaiser Permanente]] in January 2006 to form their own company.<ref name=businessweek29May2006>Carey, John. (May 29, 2006) [http://www.businessweek.com/magazine/content/06_22/b3986001.htm “Medical Guesswork”] ''Businessweek.''</ref> Archimedes helps healthcare organizations improve the quality and efficiency of their programs and services.<ref name=businessweek29May2006 /> Its proprietary software, the Archimedes Model, allows for a better understanding of the implications of medical decisions. It can be applied to a range of real world scenarios, including physiological changes, physician behavior, cost and patient decision implications.<ref name=wired15Nov2009>Kahn, Jennifer. (December, 2009) [http://www.wired.com/magazine/2009/11/ff_archimedes/all/1 “Modeling Human Drug Trials — Without the Human”] ''Wired.''</ref> The company's staff includes scientists, physicians and software engineers.<ref>{{Cite web|work=[[Archimedes, Inc]]|url= http://archimedesmodel.com/about-archimedes-incorporated.html|title=About Archimedes|date=January 1, 2010|accessdate=September 1, 2010}}</ref> |
||
The Archimedes Model is now being used by health plans, [[pharmaceutical companies]], [[governmental agencies]] and others to address issues relating to new tests and treatments, guidelines, performance, incentives, and financing.<ref>http://www.nytimes.com/2006/10/17/health/17pros.html?ref=science</ref> |
The Archimedes Model is now being used by health plans, [[pharmaceutical companies]], [[governmental agencies]] and others to address issues relating to new tests and treatments, guidelines, performance, incentives, and financing.<ref>{{cite news |
||
| title = When Advice on Diabetes Is Sound, but Ignored |
|||
| publisher = The New York Times |
|||
| date = 2006-10-17 |
|||
| url = http://www.nytimes.com/2006/10/17/health/17pros.html?_r=2&ref=science |
|||
| accessdate = 2010-8-15}}</ref> |
|||
It is also being applied to guide individual patient care.<ref>http://www.nxtbook.com/nxtbooks/medimedia/managedcare_200809/index.php?startid=Cover1&WidgetId=null&BookId=d1a085ba928e1a62afd198be891544b6#/18</ref> |
|||
Archimedes’ clients include the [[Centers for Disease Control and Prevention]] (CDC), the [[American Board of Internal Medicine]], the [[American Heart Association]], the [[American Cancer Society]], [[Humana]], Kaiser Permanente, [[Eli Lilly and Company]], [[Myriad Genetics]] and [[GlaxoSmithKline]].<ref name=Archimedesnewbenefactor>http://www.modernhealthcare.com/article/20071112/SUB/71109001</ref> |
Archimedes’ clients include the [[Centers for Disease Control and Prevention]] (CDC), the [[American Board of Internal Medicine]], the [[American Heart Association]], the [[American Cancer Society]], [[Humana]], Kaiser Permanente, [[Eli Lilly and Company]], [[Myriad Genetics]] and [[GlaxoSmithKline]].<ref name=Archimedesnewbenefactor>http://www.modernhealthcare.com/article/20071112/SUB/71109001</ref> |
Revision as of 20:36, 11 October 2010
Welcome to Wikipedia! I hope you enjoy the encyclopedia and want to stay. As a first step, you may wish to read the Introduction.
If you have any questions, feel free to ask me at my talk page — I'm happy to help. Or, you can ask your question at the New contributors' help page.
Here are some more resources to help you as you explore and contribute to the world's largest encyclopedia...
Finding your way around:
Need help?
|
|
How you can help:
|
|
Additional tips...
|
Temporary Draft: Archimedes, Inc.
File:ARCHlogoB.jpg | |
Company type | Private |
---|---|
Industry | Healthcare Modeling |
Founded | 2006 |
Headquarters | San Francisco, California, U.S. |
Key people | Dr. David Eddy, Co-founder and Chief Medical Officer Emeritus John Beasley, CEO Marc-david Cohen, PhD, Chief Science Officer Dr. Peter Alperin, Vice President of Medicine |
Website | Archimedes, Inc. |
Archimedes, Inc. is a healthcare modeling company located in San Francisco, California. It is named for the Greek mathematician Archimedes, who is generally considered to be the greatest mathematician of antiquity.
History and operations
Archimedes, Inc. was founded by David Eddy, MD PhD, and Leonard Schlessinger, PhD, when they moved on from not-for-profit managed-care organization Kaiser Permanente in January 2006 to form their own company.[1] Archimedes helps healthcare organizations improve the quality and efficiency of their programs and services.[1] Its proprietary software, the Archimedes Model, allows for a better understanding of the implications of medical decisions. It can be applied to a range of real world scenarios, including physiological changes, physician behavior, cost and patient decision implications.[2] The company's staff includes scientists, physicians and software engineers.[3]
The Archimedes Model is now being used by health plans, pharmaceutical companies, governmental agencies and others to address issues relating to new tests and treatments, guidelines, performance, incentives, and financing.[4]
It is also being applied to guide individual patient care.[5]
Archimedes’ clients include the Centers for Disease Control and Prevention (CDC), the American Board of Internal Medicine, the American Heart Association, the American Cancer Society, Humana, Kaiser Permanente, Eli Lilly and Company, Myriad Genetics and GlaxoSmithKline.[6]
Archimedes Model
The Archimedes Model combines biological, medical, and economic data with advanced mathematics and computing methods to create simulations that can address real-world healthcare questions.[2] It is a clinically realistic, validated mathematical model of human physiology, diseases, interventions, and healthcare systems. The model enables clients to simulate clinical trials and compare clinical and economic benefits between drugs and standard treatments in almost any population.[2]
The model uses object-oriented programming and runs on a distributed computing network. At its core are hundreds of ordinary and differential equations that represent human physiology and the effects of diseases.[7] The model also includes detailed aspects of healthcare systems to analyze clinical events, utilization, and costs.[1]
Archimedes validates the model by running simulations of actual clinical trials and then comparing the results of the simulation with those of the real-world trial.[7] To date, more than 50 clinical trials have been used to validate the model. The Archimedes Model is distinguished from other clinical models by its realism, its inclusion of multiple diseases in a single integrated model, its degree of clinical and logistic detail, and its validation against epidemiological studies and dozens of clinical trials.[2]
According to Richard Kahn, then-chief scientific and medical officer at the American Diabetes Association, the Archimedes Model, "...is at least ten times better than the model we use now, which is called thinking."[1]
David Eddy
David Eddy, co-founder and now Chief Medical Officer Emeritus of Archimedes, is a pioneer in evidence-based decision-making in medicine and coined the term "evidence-based."[2] He made significant advances in the theory and applications of evidence-based guidelines.[7] Eddy developed the Archimedes Model while working at Kaiser Permanente in Southern California in the early 1990s and later incubated the project at Kaiser’s Care Management Institute in Oakland, California.[7] Eddy received the Frederick W. Lanchester Prize in 1980 for the best contribution to operations research and the management sciences. In 1990, he was named “One of the Ten Most Important People in Managed Care” by Managed Healthcare Magazine, and in 2005 he received the Distingu ished Achievement Award from the Centers for Disease Control and Prevention and the Institute for Quality in Laboratory Medicine.[8]
=
Foundation support=
In 2007, the Robert Wood Johnson Foundation awarded Archimedes a $15.6 million grant to extend the power of the Archimedes Model to more health policy and healthcare decision-makers, including the United States Congress and federal agencies; medical specialty societies and nonprofit disease associations (such as the American Diabetes Association and the National Committee for Quality Assurance); government programs such as Medicare and Medicaid; and insurers and healthcare provider networks.[6] The grant was the largest to date made by Robert Wood Johnson Foundation's Pioneer Portfolio, which supports innovative projects that may lead to important breakthroughs in the future of health and healthcare.[9]
See also
References
- ^ a b c d Carey, John. (May 29, 2006) “Medical Guesswork” Businessweek.
- ^ a b c d e Kahn, Jennifer. (December, 2009) “Modeling Human Drug Trials — Without the Human” Wired.
- ^ "About Archimedes". Archimedes, Inc. 1 January 2010. Retrieved 1 September 2010.
- ^ "When Advice on Diabetes Is Sound, but Ignored". The New York Times. 2006-10-17. Retrieved 2010-8-15.
{{cite news}}
: Check date values in:|accessdate=
(help) - ^ http://www.nxtbook.com/nxtbooks/medimedia/managedcare_200809/index.php?startid=Cover1&WidgetId=null&BookId=d1a085ba928e1a62afd198be891544b6#/18
- ^ a b http://www.modernhealthcare.com/article/20071112/SUB/71109001
- ^ a b c d http://www.sys-con.com/node/545725
- ^ http://archimedesmodel.com/archimedes-newsroom .htm l
- ^ http://foundationcenter.org/pnd/news/story.jhtml?id=193100024
External links
- Archimedes, Inc.
- Eddy, David. "Evidence-Based Medicine: A Unified Approach," Health Affairs, Vol. 24, No. 1 (2005): 9-17
- Taylor, Prentiss. "Clinical Decision Making: From Theory to Practice (book review)," Journal of the American Medical Association, Vol. 276, No. 17, 6 November 1996
References
External links
- Archimedes, Inc.
- Dr. Eddy's article, "Evidence-Based Medicine: A Unified Approach"
- Dr. Eddy's JAMA publication, "Clinical Decision Making: From Theory to Practice"
- American Cancer Society
- The Robert Wood Johnson Foundation
Non-free files in your user space
Hey there Danieldis47, thank you for your contributions. I am a bot, alerting you that non-free files are not allowed in user or talk space. I removed some files I found on User talk:Danieldis47. In the future, please refrain from adding fair-use files to your user-space drafts or your talk page.
- See a log of files removed today here.
- Shut off the bot here.
- Report errors here.
Thank you, -- DASHBot (talk) 05:04, 20 July 2010 (UTC)